MedPath

The effect of continuous intake of foods containing plant extract on neutral fat, liver fat and uric acid levels.

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000040821
Lead Sponsor
IMEQRD Co., Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1.Those who are currently receiving any types of medicines and/or Chinese medical treatment (except for the medication needed). 2.Those who have or had a severe disease of the liver, kidney, heart, respiratory, endocrine and metabolic diseases. 3.Those who are treated for the dyslipidemia or hyperuricemia. 4.Those who have undergone gastrointestinal surgery (appendicitis acceptable). 5.Those who have been routinely taking foods for specified health use, health foods with functional claims or supplements, which are expected to improve body fat reduction or lipid metabolism-related test values and uric acid levels. 6.Those who cannot abstain from taking health food other than test food during the test period. 7.Those who have a current or previous history of drug and/or food allergies. 8.Heavy drinkers. 9.Those who have metals implanted in the body due to surgery etc. 10.Those who have a cardiac pacemaker or an implantable medical device placed in the body. 11.Those who have claustrophobia. 12.Those who work night shifts. 13.Those who are currently undergoing treatment for drug dependence or drug abuse or those who have a past medical history of either of htem. 14.Those who have collected or donated more than 200mL within 1 month or 400mL within 3 months of the pre-examination. 15.Those who are surrently pregnant or breastfeeding or those who want to become pregnant during the study period. 16.Those who are currently participating in another clinical trial or those who took a test product and completed another clinical trial in a month. 17.Those who were determined by the principal investigator and the sub investigator to be unsuitable for participation in this clinical trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eutral fat
Secondary Outcome Measures
NameTimeMethod
iver-spleen ratio Physical examination: body weight, body fat percentage, BMI, waist circumference , gamma-GTP, creatinine, HbA1c, glucose, Insulin, TC, HDL-C, LDL-C, uric acid questionnaire
© Copyright 2025. All Rights Reserved by MedPath